Rebel
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Changing the subject doesn’t make it less absurd. One has nothing to do with the other. I know how angry you are, but we are all in this state of limbo and will have to wait it out. Meanwhile, making up ridiculous scenarios based on nothingness is a waste of bandwidth. Try focusing on the positive and not the drama. You will feel better.
lol. Simply absurd.
12 on a scale of 1 to 10 on the absurd index.
They aren't the ones who should be "disgorged" because they haven't committed any crimes. If you disagree, point to one crime, just one, that you can back up with FACTS. Don't want to hear opinions or about delinquent financials or last April ...no crimes there.
You keep referring to ExSpurt Grey Market, but there is no such thing.
Yup, and they take the very same actions against stock manipulators.
As I said, the PROOF is out there. All you have to do is find it.
That is absurd. You are saying they went through all that time, expense, and hard work to become CLIA certified just so they could pump the stock and then just let it expire? Oh please, gIve me a break. lol.
It didn’t expire. Proof of that fact can be found on this very board shared by an astute poster a few weeks ago.
Short interest IS the number of shares shorted and not yet covered. Same thing.
Yes because they are now CLIA certified and they weren’t back then; that happened in May, 2018 and was.a HUGE step up for ARYC.
Well thank you. Same to you. Didn't expect this coronavirus GLITCH, so patience is truly a virtue here, and the share prices are simply amazing!
A high impact sale is a GREAT IDEA and will bring in loads of cash to pay down debt, or whatever. It is NOT a liquidation sale!
Happy weekend to you too! Sorry you are so down on VYST.
I'm not!
I have read it and scanned it, and the only reference to "liquidation" came from your post. lol. Times have been incredibly tough for ALL businesses, large and small. Rotman's should pull through. They have an incredibly loyal customer base all over New England.
They continued to operate via internet, phone, text, just like the majority of businesses in this country had to do. Plus, they were taking appointments for people who wanted to visit the showroom before they purchased an item, and they were taking on-line orders.
They are doing the best they can...that's all anyone can do.
Say what?? Rotman's Furniture is not liquidating. In fact, they should re-open around June 8th under Governor Baker's 2nd phase reopen plan for Massachusetts. They never closed completely anyway. There is no indication of any "liquidation" plans anywhere. Trying to start a rumor?
https://www.rotmans.com/?gclid=CjwKCAjw2uf2BRBpEiwA31VZj8AV-J3AZTqfEPXYWDc3FroX8tfyZunnMQjzTWtcGKtaTm1asThyjhoC1EoQAvD_BwE
Thanks Mike! You are right. The Feds DO allow it. FDA "approval" would be huge and may be forthcoming, but the fact that ARYC can legally apply its test for ovarian cancer right now with the FDA's blessing, must mean that its tests for Parkinson’s disease, colon cancer, and male fertility would be in the same LDT category, just like their COVID-19 test. Even though ARYC's technology has been around for a while, it is still relatively new to the world and the FDA. This is all GOOD.
Found this on the subject at the FDA website in case anyone is interested:
"A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.
LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.
While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.
The FDA does not consider diagnostic devices to be LDTs if they are designed or manufactured completely, or partly, outside of the laboratory that offers and uses them.
LDT’s are important to the continued development of personalized medicine, so it is important that in vitro diagnostics are accurate so that patients and health care providers do not seek unnecessary treatments, delay needed treatments, or become exposed to inappropriate therapies."
That's what I said - for research purposes. They do not claim it's FDA approved. It's still in the Arrayit store "for research purposes." Why would the LA people just pop that in unless Arrayit approved of them doing so? It wasn't in there initially.
That's just one of the many questions that hopefully will be answered by the company at some point! That should happen any day or minute now.... lol.
From Arrayit.com (not all that clear either)
Oncology
Advanced Cancer Detection
Microarray tests for ovarian cancer, colon cancer and other cancers measure the activation of the immune system in response to tumor cell development. Pre-symptomatic and early stage cancer detection improves patient prognosis and healthcare treatment options. Talk to your Doctor about other wellness testing.
What a horrible thing to say. Boo.
As it states on the FDA website, ARYC has validated the test, but maybe (probably) the test needs to undergo further validation and proficiency testing with an independent lab as they did with their allergy and asthma tests, which as we all know, they "aced," opening the door and ultimately being approved for Medicare, Medicaid, and other insurers.
I would imagine that just getting their hands on samples to test would be a challenge, among many other challenges they would have to face in the general chaos of this pandemic.
"Because the acceptable test range is narrow, acing five consecutive rounds of PT is extremely demanding and requires a high degree of testing accuracy. Outstanding PT scores are valuable commercially because they expedite reimbursement by Medicare, Medicaid and the top commercial payors."
https://www.globenewswire.com/news-release/2019/05/20/1827608/0/en/Arrayit-Corporation-Aces-Fifth-Consecutive-Proficiency-Testing-Round-with-a-Top-Laboratory-Medicine-Proficiency-Testing-Leader.html
I believe it is allowed for research purposes while it awaits FDA approval.
The test did receive "Institutional Review Board (IRB) approval from the United States Food and Drug Administration (FDA) to validate ovarian cancer specimens pursuant to 510(k) approval of OvaDx(R), a pre-symptomatic ovarian cancer test that aids the monitoring of women diagnosed with ovarian cancer.'
Overview of Testing Services
Our technology platform and CLIA certified laboratory, which is authorized to perform “high complexity tests,” has the capability of processing and testing millions of samples per month as we add staff and expand our readily available proprietary, in-house equipment. Antibody testing for the Covid-19 is what America and the world needs in order to compile specific data to create solid planning measures necessary to re-open economies here in America and around the world.
Register now to receive an email to enroll in our State Licensed & CLIA certified lab, now testing for allergies/asthma, and/or COVID-19 testing, We also provide Pre-symptomatic Ovarian Cancer screening services.
https://antibodycovidtest.com/
Briefing on COVID-19 Testing and methodology and availability:
- Gabbert Medical and Arrayit.
Coronaviruses cause illness from the common cold to Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV) and now the novel coronavirus (nCoV “COVID-19”) - a new strain that has not been previously identified in humans up until late 2019 in China.
The lab performs an immunoassay for detection of 2019-Novel Coronavirus (2019-nCoV “COVID-19”) from samples collected by:
1. whole blood by finger stick collection
Tests are conducted in Arrayit’s CLIA, State and Federally approved lab eligible for Medicare, State, Federal and commercial insurance reimbursement and patient/Employer cash pay or self-insurance.
Claims are billed by Arrayit for COVID-19 and Allergy by Doctor authorization.
Arrayit SARS-CoV-2 (COVID-19) Screening Test
Arrayit Corporation offers a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) blood test based on advanced microarray technology and finger stick blood collection through our clinical laboratory in Sunnyvale licensed by the State of California Department of Public Health (CDPH), Clinical Laboratory Improvement Amendments (CLIA) and proficiency-tested by the College of American Pathologists (CAP).
Patient blood specimens are collected on blood cards, shipped to our laboratory and microarray-tested for immunoglobulin G (IgG) antibody reactivity to twelve SARS-CoV-2 proteins in a miniaturized and multiplexed microarray format. High-speed robotics and fully automated data processing ensure speed, accuracy and scalability to a large patient volume.
Healthcare providers receive a 48-72-hour turnaround, digital and easy-to read test reports, and full ordering and report retrieval privileges through our Patient Data Solutions on-line portal.
Doctors can use our SARS-CoV-2 testing services to complement patient diagnoses based on symptoms, and reverse transcription polymerase chain reaction (RT-PCR) tests utilizing upper respiratory nasopharyngeal and oropharyngeal swabs and lower respiratory sputum.
EDUCATIONAL DOCUMENTS IN FIRST DRAFT FORM
With 90-100% accuracy, The Arrayit SARS-CoV-2 test provides actionable IgG antibody data to assist in identifying, managing and treating SARS-CoV-2 illness in patients who may have been exposed to the virus in the workplace and through contact with infected persons at large public gatherings and through travel to domestic and international destinations.
Arrayit SARS-CoV-2 testing offers the advantages of speed, simplicity and high throughput patient testing in a clinical laboratory, and may be particularly useful in identifying carriers that score negative in the SARS-CoV-2 RT-PCR test due to SARS-CoV-2 latency or low virus titers.”
Medical officials are pointing out it’s high pollen season - Allergies cause:
? congestion
? runny nose
? mouth breathing- which causes sore throat These symptoms together present as flu symptoms.
It’s smart to test for Allergies so we can treat them or eliminate them as a cause of the symptoms. The SARS-COV-2 (COVID-19) test is being combined with the Environmental Allergen Panel sample which is derived from the same Finger stick (prick) Blood Card as described above.
https://www.facebook.com/GabbertMedical/posts/covid-19-testing-compels-allergy-testingwe-must-not-confuse-allergy-symptoms-wit/831367814039740/
lol. Now that's a lot of ASSumptions based on....hmmmm....nothing! Rotman's is not and never has been a failing furniture store; in fact, quite the opposite. No, you may not buy my shares at these ridiculous prices. If you need more shares, try buying at the ask. You won't lose. Good luck!
:)
Yes! I second that emotion.
:))
Q: What laboratories are offering serology tests under the policy outlined in Section IV.D of the Policy for Coronavirus Disease-2019 Tests? (Updated 6/2)
A: Arrayit Corporation
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-testing-sars-cov-2
What a fine idea SG! Under their theory, every public company could be under SEC investigation. Uh oh.
lol.
Unless you believe Dr. Schena wants to be locked up, there is NO WAY he would make up those claims in Twitter, which is a SEC-sanctioned method of shareholder communication. That would make NO sense.
No it's not! lol.
No, it's a tier called the Expert Market. If it were Gray Sheets, then that's what they would call it. It was created to offset some of the restrictions of the grays.
The Expert market is different from the gray sheets. The public can't see the bid or ask, but they do exist. Look it up.
Blame the Experts for the price decline. Buy orders are getting filled for LESS than the bid prices.
There is no reason to believe those tweets are absurd or untrue. If you don't believe them, then that's AOK! Mark would not be interested in doing time in the pokey, so I don't believe any of those tweets were made up for the fun of it.
It is just absurd to make a claim that it is "evident" when you have nothing to back up that statement. I do, however, hope the SEC continues its investigation as to the back story.
Apparently ARYC IS valued by several research entities, as well as several government and military entities. AND, ARYC is still on the FDA's list of CLIA labs offering their COVID-19 antibody tests to doctors and clinics right now, and YES, that is with the blessing of the FDA.
The SEC did its thing and you DO NOT know anything beyond that. I hope they do continue to investigate so that the truth may be finally be revealed.
lol. Those research reports are NOT "put out by the company."
Nice. There's Arrayit again! Wonder why? lol. Found this too (Arrayit is listed twice): Oligonucleotide DNA Microarrays Market COVID-19 Impact, 2020 Current Scope, Solutions, Demand, Platforms, Substantial Growth, Key Players Analysis And Segmentation Till 2029
The Oligonucleotide DNA Microarrays market is disintegrating and is highly competitive owing to the presence of major players and regional players. However, four major players dominate the market. All the dominant players are performing better than one another in one or two parameters and in this way, the competition in the Oligonucleotide DNA Microarrays market is intensifying.
The leading vendors included inside the reports are:
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Arrayit
Biometrix Technology
Savyon Diagnostics
WaferGen
Segmentation by type and analysis of the Oligonucleotide DNA Microarrays market
Gene expression
Genotyping
Genome cytogenetics
Segmentation by geography and analysis of the bicycle motors market
South America Oligonucleotide DNA Microarrays Market Covers Colombia, Argentina and Brazil.
North America Oligonucleotide DNA Microarrays Market Covers United States, Mexico and Canada.
Europe Oligonucleotide DNA Microarrays Market Covers Germany, France, UK, Italy and Russia.
The Middle East and Africa Oligonucleotide DNA Microarrays Market Covers UAE, Nigeria, South Africa, Saudi Arabia and Egypt.
Asia Pacific Oligonucleotide DNA Microarrays Market Covers China, Japan, Southeast Asia, India and Korea.
https://apnews.com/7e21279d422cc8e330206acca908c5d9
That’s NOT from Arrayit. Fake.
You are not alone, Jeff. Yup, ARYC is still in business, still offering their COVID-19 and allergy testing services to gazillions of doctors and clinics, still on "the list." All good.
Just a matter of time before something awesome kicks in.
Run run run! Laboratories that have notified FDA that they have validated and intend to offer serology tests as set forth in Section IV.D:
Arrayit Corporation - H - Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high complexity tests - Not FDA Authorized.
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-testing-sars-cov-2
Relax, it's not like it's the ONLY thing SRNE has going on. The current share price isn't anywhere close to the analysts' consensus of $24.00 (before the company had anything to do with COVID-19). With successful clinical trials, followed by manufacturing and distribution of the product, who know how high Sorrento can go.
Or, of course some big biotech might want to put SRNE into their shopping cart!